Latest News about BPMC
Recent news which mentions BPMC
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 17, 2022
From Benzinga
Analyst Sees Deteriorated Treatment Effect Of Blueprint's Much Awaited Mastocytosis Data
August 17, 2022
Tickers
BPMC
From Benzinga
From Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
From Benzinga
U.S. Stocks Open Lower; Nasdaq Down 150 Points
August 17, 2022
From Benzinga
Blueprint Medicines Shares Fall After Topline Results From Late-Stage Neoplastic Disorder Study
August 17, 2022
Tickers
BPMC
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 17, 2022
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
3 Biotech Stock Picks From This Wedbush Analyst
July 27, 2022
From Benzinga
From Benzinga
This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation'
June 30, 2022
From Benzinga
From Benzinga
SVB Leerink Maintains Market Perform Rating for Blueprint Medicines: Here's What You Need To Know
June 13, 2022
Tickers
BPMC
From Benzinga
10 Biggest Price Target Changes For Monday
June 13, 2022
From Benzinga
91 Biggest Movers From Friday
June 13, 2022
From Benzinga
44 Stocks Moving In Friday's Mid-Day Session
June 10, 2022
From Benzinga
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Wednesday
June 01, 2022
From Benzinga
3 Small-Caps That Might Be Acquisition Candidates
May 09, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.